REFERENCES
[1] S.S. Virani, A. Alonso, E.J. Benjamin, et al, Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association, Circulation. 141 (2020). https://doi.org/10.1161/CIR.0000000000000757.
[2] D.S. Wald, J.K. Morris, N.J. Wald, et al, Randomized Trial of Preventive Angioplasty in Myocardial Infarction, N. Engl. J. Med. 369 (2013) 1115–1123. https://doi.org/10.1056/NEJMoa1305520.
[3] H. Xu, X. Zhang, J. Li, et al, Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials, BMC Cardiovasc. Disord. 19 (2019) 91. https://doi.org/10.1186/s12872-019-1073-8.
[4] C. Wu, A.-M. Dyer, S.B. King, et al, Impact of Incomplete Revascularization on Long-Term Mortality After Coronary Stenting, Circ. Cardiovasc. Interv. 4 (2011) 413–421. https://doi.org/10.1161/CIRCINTERVENTIONS.111.963058.
[5] Z. Gao, B. Xu, Y. Yang, et al, Long-term outcomes of complete versus incomplete revascularization after drug-eluting stent implantation in patients with multivessel coronary disease, Catheter. Cardiovasc. Interv. 82 (2013) 343–349. https://doi.org/10.1002/ccd.24799.
[6] B.R. Chaitman, A.D. Rosen, D.O. Williams, et al, Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial, Circulation. 96 (1997) 2162–2170. https://doi.org/10.1161/01.CIR.96.7.2162.
[7] P.W. Serruys, M.-C. Morice, A.P. Kappetein, et al, Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease, N. Engl. J. Med. 360 (2009) 961–972. https://doi.org/10.1056/NEJMoa0804626.
[8] M.E. Farkouh, M. Domanski, L.A. Sleeper, et al, Strategies for Multivessel Revascularization in Patients with Diabetes, N. Engl. J. Med. 367 (2012) 2375–2384. https://doi.org/10.1056/NEJMoa1211585.
[9] E.J. Velazquez, K.L. Lee, R.H. Jones, et al, Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy, N. Engl. J. Med. 374 (2016) 1511–1520. https://doi.org/10.1056/NEJMoa1602001.
[10] M.R. Patel, J.H. Calhoon, G.J. Dehmer, et al, ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease, J. Am. Coll. Cardiol. 69 (2017) 2212–2241. https://doi.org/10.1016/j.jacc.2017.02.001.
[11] C. Spadaccio, U. Benedetto, Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? —a review of the evidences on coronary artery disease, Ann. Cardiothorac. Surg. 7 (2018) 506–515. https://doi.org/10.21037/acs.2018.05.17.
[12] P.T. O’Gara, F.G. Kushner, D.D. Ascheim, et al, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, Circulation. 127 (2013). https://doi.org/10.1161/CIR.0b013e3182742cf6.
[13] L. Lambert, Association Between Timeliness of Reperfusion Therapy and Clinical Outcomes in ST-Elevation Myocardial Infarction, JAMA. 303 (2010) 2148. https://doi.org/10.1001/jama.2010.712.
[14] B.R. Brodie, T.D. Stuckey, T.C. Wall, et al, Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction, J. Am. Coll. Cardiol. 32 (1998) 1312–1319. https://doi.org/10.1016/S0735-1097(98)00395-7.
[15] C.P. Cannon, Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction, JAMA. 283 (2000) 2941. https://doi.org/10.1001/jama.283.22.2941.
[16] 2014 Introduction to the NRD. Healthcare Cost and Utilization Project (HCUP), Agency Healthc. Res. Qual. Rockv. M. (n.d.). www. hcup-us. ahrq. gov/db/nation/nrd/NRD_Introduction_2014. jsp.
[17] K.L.C. Gibson T, Casto A, Young J, Impact of ICD-10- CM/PCS on Research Using Administrative Databases, . . HCUP Methods Ser. Rep. # 2016- 02 ONLINE. July 25, 2016. U.S. Agency Healthc. Res. Qual. (n.d.). available: http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp.
[18] R. Khera, S. Angraal, T. Couch, et al, Adherence to Methodological Standards in Research Using the National Inpatient Sample, JAMA. 318 (2017) 2011. https://doi.org/10.1001/jama.2017.17653.
[19] M.A. Pourhoseingholi, A.R. Baghestani, M. Vahedi, How to control confounding effects by statistical analysis., Gastroenterol. Hepatol. from Bed to Bench. 5 (2012) 79–83. http://www.ncbi.nlm.nih.gov/pubmed/24834204.
[20] M.S.H.P. 2014. McDonald JH. Handbook of Biological Statistics. 3rd ed. Baltimore, No Title, (n.d.).
[21] T. Doenst, A. Haverich, P. Serruys, et al, PCI and CABG for Treating Stable Coronary Artery Disease, J. Am. Coll. Cardiol. 73 (2019) 964–976. https://doi.org/10.1016/j.jacc.2018.11.053.
[22] S.-J. Park, J.-M. Ahn, Y.-H. Kim, et al, BEST Trial Investigators, Trial of everolimus-eluting stents or bypass surgery for coronary disease., N. Engl. J. Med. 372 (2015) 1204–12. https://doi.org/10.1056/NEJMoa1415447.
[23] M. Chang, C.W. Lee, J.-M. Ahn, et al, Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome., Am. J. Cardiol. 120 (2017) 380–386. https://doi.org/10.1016/j.amjcard.2017.04.038.
[24] P. Freitas, M. Madeira, L. Raposo, et al, Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Myocardial Infarction and Left Main or Multivessel Coronary Disease., Am. J. Cardiol. 123 (2019) 717–724. https://doi.org/10.1016/j.amjcard.2018.11.052.
[25] S.J. Head, M. Milojevic, D.P. Taggart, et al, Current Practice of State-of-the-Art Surgical Coronary Revascularization, Circulation. 136 (2017) 1331–1345. https://doi.org/10.1161/CIRCULATIONAHA.116.022572.
[26] S.J. Head, S. Kaul, M.J. Mack, et al, The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease, Eur. Heart J. 34 (2013) 2510–2518. https://doi.org/10.1093/eurheartj/eht059.
[27] D.P. Taggart, R. D’Amico, D.G. Altman, Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries., Lancet (London, England). 358 (2001) 870–5. https://doi.org/10.1016/S0140-6736(01)06069-X.